DNER and diffuse large B-cell lymphoma: Some other BET inhibitors were also shown to be effective, for example iBET in diffuse large B-cell lymphoma [16,223], iBET151 (diffuse large B-cell lymphoma, colorectal cancer, ovarian cancer [224,225,226], OTX-015 in diffuse large B-cell lymphoma and neuroblastoma [16,227,228], volasertib in ovarian cancer [226], BAY 1238097 in melanoma [228], etc. (Table 3).